The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Summary
- Eligibility
- for people ages up to 22 years (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Elliot Stieglitz
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- LLS PedAL Initiative, LLC
- ID
- NCT04726241
- Study Type
- Observational
- Participants
- Expecting 960 study participants
- Last Updated